RJF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Raymond James Financial Inc is not a strong buy for a beginner, long-term investor at this moment. While the company has a solid business model and positive long-term growth potential, the mixed financial performance, neutral technical indicators, and lack of significant positive catalysts suggest waiting for a clearer entry point.
The MACD is negative and contracting (-0.428), RSI is neutral at 52.319, and moving averages are converging, indicating no strong trend. The stock is trading near its R1 resistance level of 160.788 in pre-market, with support at 157.142. Overall, the technical indicators suggest a neutral trend.
Barclays initiated coverage with an Overweight rating and a $191 price target, citing long-term growth potential and attractive valuation. Gross margin increased by 2.06% YoY in the latest quarter.
Net income dropped by 6.19% YoY, and EPS decreased by 2.45% YoY in the latest quarter. Analysts have mixed views, with some lowering price targets and estimates. Broader market concerns, including geopolitical risks and upcoming tariffs, may weigh on the stock.
In Q1 2026, revenue increased by 3.27% YoY to $4.078 billion, but net income dropped by 6.19% YoY to $561 million. EPS declined by 2.45% YoY to 2.79, while gross margin improved by 2.06% YoY to 89.19. The financial performance shows modest revenue growth but declining profitability.
Analyst ratings are mixed. Barclays initiated coverage with an Overweight rating and a $191 price target, highlighting long-term growth potential. However, TD Cowen lowered its price target to $181, citing mixed views on margins and near-term growth. BofA raised its price target to $198 but maintained a Neutral rating.
